Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Canis

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Scientific Reports|October 3, 2018
High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck CarcinomaPhilipp Baumeister, Alessandra Hollmann, Julia Kitz, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 14, 2018
Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosaHannah Pellkofer, Friedrich Ihler, Bernhard G Weiss, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Blood|April 22, 2024
Procoagulant platelets promote immune evasion in triple-negative breast cancerJohanna B Schaubaecher, Bojan Smiljanov, Florian Haring, et al.
Molecular Oncology|December 19, 2020
Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomasHenrik Schinke, Theresa Heider, Timm Herkommer, et al.
Molecular Cancer|September 8, 2022
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancerHenrik Schinke, Enxian Shi, Zhongyang Lin, et al.
EMBO Molecular Medicine|May 17, 2021
uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophilsBernd Uhl, Laura A Mittmann, Julian Dominik, et al.
Frontiers in Immunology|February 27, 2023
Vitronectin promotes immunothrombotic dysregulation in the venular microvasculatureBernd Uhl, Florian Haring, Julia Slotta-Huspenina, et al.
Molecular Cancer|March 23, 2025
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancerJiefu Zhou, Min He, Qiong Zhao, et al.
Cancers|August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Scientific Reports|October 3, 2018
High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck CarcinomaPhilipp Baumeister, Alessandra Hollmann, Julia Kitz, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 14, 2018
Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosaHannah Pellkofer, Friedrich Ihler, Bernhard G Weiss, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 31, 2015
Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local ControlJessica H Maxwell, Lester D R Thompson, Margaret S Brandwein-Gensler, et al.
Blood|April 22, 2024
Procoagulant platelets promote immune evasion in triple-negative breast cancerJohanna B Schaubaecher, Bojan Smiljanov, Florian Haring, et al.
Molecular Oncology|December 19, 2020
Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomasHenrik Schinke, Theresa Heider, Timm Herkommer, et al.
Molecular Cancer|September 8, 2022
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancerHenrik Schinke, Enxian Shi, Zhongyang Lin, et al.
EMBO Molecular Medicine|May 17, 2021
uPA-PAI-1 heteromerization promotes breast cancer progression by attracting tumorigenic neutrophilsBernd Uhl, Laura A Mittmann, Julian Dominik, et al.
Frontiers in Immunology|February 27, 2023
Vitronectin promotes immunothrombotic dysregulation in the venular microvasculatureBernd Uhl, Florian Haring, Julia Slotta-Huspenina, et al.
Molecular Cancer|March 23, 2025
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancerJiefu Zhou, Min He, Qiong Zhao, et al.
Cancers|August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Pageof 20